Ticker brief

VNDA VANDA PHARMACEUTICALS INC

Consumer, Non-cyclical · Pharmaceuticals

last close
$4.01
1 day
-1.0%
14 days
-12.3%
mkt cap
$373.4M
signals 14d
7
authors 14d
4
crowd 14d
-2.3σ
Options inteloptions-surface reads · latest available day per source
metricreadingcontext
IV — ATM 30d67%IV/HV 1.60× (as of 2026-03-23)
Skew — 25Δ RR 30d-0.07425Δ call IV − put IV
Net dealer OI (NDOI)+0.60 thin5-session Δ -2.29 (as of 2026-03-23)
OI alarmquietlast alarm 2026-02-25 (z=4.3)
Sentiment — last 14 days
daily mean sentiment, 2026-10-09 → 2026-10-16 · now +0.00 (−1 bearish … +1 bullish)
Who spoke4
authorgradetrader scoresignalsmean sent
@BPharmCatalystC·3-0.22
@PrismMarketViewC·2-0.25
@fwpharmaB-1.911-0.50
@OpenOutcrierC·1-0.50
Recent signals7of 7 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-16@BPharmCatalyst+0.00Publishes a biotech watchlist for catalysts expected in mid-winter 2026.-0.5%
2026-10-15@PrismMarketView-0.60Vanda's Phase III anxiety study missed its primary endpoint and was put on hold.-5.4%
2026-10-15@OpenOutcrier-0.50Vanda's anxiety-drug trial failed.-5.4%
2026-10-15@fwpharma-0.50Vanda paused a social-anxiety program after a late-stage trial miss.-5.4%
2026-10-14@BPharmCatalyst-0.65VNDA reports that its Phase 3 VQW-765 program failed to meet the primary endpoint.-5.0%
2026-10-09@PrismMarketView+0.10Reviews mental-health stocks, sector milestones, performance and clinical risks.-12.3%
2026-10-09@BPharmCatalyst+0.00Six-month watchlist of upcoming PDUFA catalyst decisions; ticker list capped at six.-12.3%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.